Drug intelligence / Profile preview

maytenus ilicifolia

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Maytenus ilicifolia is a medicinal plant native to South America, especially Brazil and Argentina, commonly known as "espinheira santa." It is widely used in traditional medicine for its anti-ulcerogenic, anti-inflammatory, antioxidant, analgesic, cytoprotective and wound-healing properties. The primary indications are the treatment of gastric ulcers, gastritis, dyspepsia (indigestion), and other digestive disorders. Its leaves contain various bioactive compounds including polyphenols (tannins and flavonoids), triterpenes (such as friedelina and friedelanol), kaempferol glycosides, quercetin derivatives and others. Mechanistically, Maytenus ilicifolia exhibits antioxidant effects that protect normal cells from oxidative stress; it also reduces gastric acid secretion via specific polyphenolic constituents[4][6][8]. Some studies suggest cytotoxic activity against cancer cell lines through induction of apoptosis involving caspase-3 activation and Bcl-2 downregulation[8]. Additionally, extracts can inhibit cytochrome P450 3A (CYP3A) enzyme activity as well as P-glycoprotein-mediated drug transport in vitro[1], indicating potential for herb-drug interactions. Clinical studies show good tolerability up to 2000 mg/day with minor reversible side effects such as dry mouth or increased urination[6].

Other names
espinheira santaMaytenusCelastraceae maytenus ilicifolia
02

Targets

ABCB1 (P-glycoprotein)CYP3A (CYP3A family)

Beyond the preview

Go deeper on maytenus ilicifolia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on maytenus ilicifolia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call